T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
LXP Industrial Trust
LXP
$3.58B
| $1.34M | ﹤0.01% |
30,043
+558
| +2% | +$27.4K |
|
1652
Senti Biosciences Holdings
SNTI
$12M
| $1.34M | ﹤0.01% |
314,712
-24,621
| -7% | -$169K |
|
1653
Crane NXT
CXT
$2.96B
| $1.33M | ﹤0.01% |
24,002
+2,782
| +13% | +$161K |
|
1654
ArcBest
ARCB
$3.28B
| $1.33M | ﹤0.01% |
13,103
-12,490
| -49% | -$1.31M |
|
1655
First Merchants
FRME
$2.72B
| $1.33M | ﹤0.01% |
47,789
+1,488
| +3% | +$44.6K |
|
1656
Corcept Therapeutics
CORT
$12.1B
| $1.33M | ﹤0.01% |
48,685
+2,042
| +4% | +$59.1K |
|
1657
Liberty Media Series A
FWONA
$23.7B
| $1.33M | ﹤0.01% |
23,458
-2,729
| -10% | -$166K |
|
1658
Bank of Hawaii
BOH
$3.13B
| $1.32M | ﹤0.01% |
26,640
+3,707
| +16% | +$191K |
|
1659
Kontoor Brands
KTB
$4.65B
| $1.32M | ﹤0.01% |
30,103
+1,464
| +5% | +$64.1K |
|
1660
Tanger
SKT
$4.42B
| $1.32M | ﹤0.01% |
58,482
+5,105
| +10% | +$119K |
|
1661
Fortrea Holdings
FTRE
$1.69B
| $1.32M | ﹤0.01% |
+46,055
| New | +$1.36M |
|
1662
Progress Software
PRGS
$1.79B
| $1.32M | ﹤0.01% |
25,053
+2,457
| +11% | +$144K |
|
1663
Graham Holdings Company
GHC
$5.03B
| $1.32M | ﹤0.01% |
2,259
+26
| +1% | +$15.1K |
|
1664
Renasant Corp
RNST
$4B
| $1.32M | ﹤0.01% |
50,239
-914
| -2% | -$25.7K |
|
|
PDCO
1665
DELISTED
Patterson Companies, Inc.
PDCO
| $1.31M | ﹤0.01% |
44,289
-20,976
| -32% | -$666K |
|
1666
Appian
APPN
$2.49B
| $1.31M | ﹤0.01% |
28,743
+1,967
| +7% | +$94.2K |
|
1667
Resideo Technologies
REZI
$3.1B
| $1.31M | ﹤0.01% |
82,845
+5,488
| +7% | +$92.3K |
|
1668
Dole
DOLE
$1.23B
| $1.31M | ﹤0.01% |
112,751
+44,356
| +65% | +$554K |
|
1669
Dorman Products
DORM
$3.95B
| $1.3M | ﹤0.01% |
17,195
+1,030
| +6% | +$83.8K |
|
1670
Dine Brands
DIN
$462M
| $1.3M | ﹤0.01% |
26,317
+1,343
| +5% | +$75K |
|
1671
DNOW Inc
DNOW
$3.04B
| $1.29M | ﹤0.01% |
108,850
-1,397
| -1% | -$15.6K |
|
1672
Griffon
GFF
$4.8B
| $1.29M | ﹤0.01% |
32,572
+524
| +2% | +$21.5K |
|
|
DOOR
1673
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.29M | ﹤0.01% |
13,854
+841
| +6% | +$84.6K |
|
1674
Walker & Dunlop
WD
$1.45B
| $1.29M | ﹤0.01% |
17,348
+805
| +5% | +$68K |
|
1675
IonQ
IONQ
$18.2B
| $1.28M | ﹤0.01% |
86,090
+9,126
| +12% | +$143K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.